Rozpocznij
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Brak transakcji
Zobacz na super wykresach
Przegląd Finanse Pomysły Dyskusje Dane techniczne Prognoza Sezonowość
Obligacje

Obligacje ABBV

Poniżej znajduje się lista obligacji korporacyjnych ABBVIE INC. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol
YTM %
Wolumen
Cena %
Kupon %
Termin zapadalności
Kwota niezapłacona
Wartość nominalna
Min. kw. nominału
Emitent
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,90%60 K76,07%4,85%2044-06-1565,232 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,72%20 K76,61%4,63%2042-10-0167,493 M USD1 000,00 USD2 000,00 USDActavis, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,44%10 K79,20%4,75%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,75%64 K90,42%4,55%2035-03-15107,646 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,70%50 K89,00%3,20%2029-11-2162,515 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,43%5,244 M101,28%5,50%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,37%50 K90,96%4,63%2042-10-01389,217 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,34%100 K93,65%4,85%2044-06-151,008 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,34%4,136 M101,07%5,40%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,31%1,324 M88,93%4,40%2042-11-062,599 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,29%2,03 M93,90%4,88%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,29%660 K100,82%5,35%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,28%092,22%4,70%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,28%5,3 M93,04%4,75%2045-03-15827,091 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,26%088,93%4,45%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,23%197 K85,18%4,25%2049-11-215,745 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,13%10,959 M88,27%4,05%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,02%093,59%4,30%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4,97%096,09%4,50%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,97%536 K96,58%4,55%2035-03-151,681 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,90%18,427 M101,16%5,05%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,78%099,04%3,80%2025-03-15130,225 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,74%096,53%2,95%2026-11-219,245 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,71%1,514 M101,32%4,95%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,57%8,212 M100,92%4,80%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,54%30,129 M93,92%3,20%2029-11-215,437 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,46%098,16%3,20%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,44%6,292 M99,29%4,25%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,41%9,093 M100,87%4,80%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,40%627 K97,18%2,95%2026-11-213,991 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,28%099,33%3,60%2025-05-143,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,11%1,227 M99,70%3,80%2025-03-152,889 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3,85%095,43%2,63%2028-11-1572,107 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3,82%092,90%2,13%2029-06-0136,462 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,07%0121,31%4,25%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,03%0126,76%4,75%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,96%0128,71%4,85%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,95%089,20%1,25%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,81%097,05%2,13%2029-06-01506,088 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,77%099,43%2,63%2028-11-15427,793 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,72%097,72%2,13%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2,69%5,101 M99,91%2,60%2024-11-213,739 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2,60%094,61%0,75%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,02%0123,74%4,55%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%0102,15%3,80%2025-03-151,268 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%0106,34%2,60%2024-11-2110,86 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1 000,00 USD2 000,00 USDAbbVie, Inc.